Study design and participant recruitment IMPACC is a prospective longitudinal study that enrolled >1,000 hospitalized patients with COVID-19, as previously described27,32,55,56,57,58. Participants 18 years and older were recruited from 20 hospitals across 15 academic institutes within the USA (Fig. 1a). All participants were confirmed to be SARS-CoV-2-positive by reverse transcription PCR (RT–PCR) testing and no participants